Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Epidemiology journal rankings 2024
187 ranked journals · Subfield in Medicine
Epidemiology has 187 ranked journals in 2024. The median journal has an OJR of 0.76, below the world average of 1.00, down 0.03 on 2023; Q1 starts at OJR 1.18. The top three are Journal of Hepatology, The Lancet. Gastroenterology & hepatology, and Autophagy.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
187 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1Journal of HepatologyElsevier BV · Denmark | 5.99Q1 | 16.60 0.47 up from 2023 | 1,163 | 16% | $5,500 | ||
2The Lancet. Gastroenterology & hepatologyElsevier BV · United Kingdom | 5.45Q1 | 17.45 2.88 up from 2023 | 543 | 28% | $7,280 | ||
3AutophagyTaylor & Francis · United States | 4.65Q1 | 12.62 1.52 up from 2023 | 562 | 99% | — | ||
4Nature Reviews Gastroenterology & HepatologyNature Portfolio · United Kingdom | 4.55Q1 | 18.66 0.46 up from 2023 | 454 | 19% | — | ||
5MetabolismElsevier BV · United States | 3.70Q1 | 12.17 1.25 up from 2023 | 410 | 38% | $5,340 | ||
6Clinical and Molecular HepatologyOAKorean Association for the Study of the Liver · South Korea | 3.54Q1 | 13.06 4.41 up from 2023 | 246 | 100% | $32 | ||
7Tumour Virus ResearchOAElsevier BV · Netherlands | 2.97Q1 | 10.61 4.88 up from 2023 | 48 | 100% | $3,110 | ||
8Infectious Disease Clinics of North AmericaElsevier BV · United States | 2.95Q1 | 5.17 2.58 down from 2023 | 138 | 21% | $4,050 | ||
9StrokeLippincott Williams & Wilkins · United States | 2.67Q1 | 7.88 0.86 up from 2023 | 1,535 | 15% | — | ||
10Clinical Gastroenterology and HepatologyElsevier BV · United States | 2.52Q1 | 7.18 0.91 up from 2023 | 1,249 | 42% | $4,470 | ||
11PneumoniaOABioMed Central · United Kingdom | 2.41Q1 | 6.62 2.09 down from 2023 | 40 | 100% | $2,690 | ||
12European Stroke JournalSAGE Publishing · United Kingdom | 2.31Q1 | 4.98 2.51 down from 2023 | 268 | 100% | $4,400 | ||
13International Journal of StrokeSAGE Publishing · United Kingdom | 2.30Q1 | 9.47 2.62 up from 2023 | 354 | 63% | $4,400 | ||
14The Lancet Regional Health - Western PacificOAElsevier BV · United Kingdom | 2.18Q1 | 6.20 0.60 up from 2023 | 800 | 100% | $4,250 | ||
15Journal of StrokeOASouth Korea | 2.00Q1 | 6.74 2.51 up from 2023 | 152 | 100% | — | ||
16Hepatology CommunicationsOALippincott Williams & Wilkins · United States | 2.00Q1 | 5.16 0.78 down from 2023 | 734 | 100% | $2,700 | ||
17Harm Reduction JournalOABioMed Central · United Kingdom | 1.73Q1 | 4.48 0.32 down from 2023 | 442 | 100% | $3,290 | ||
18Alimentary Pharmacology & TherapeuticsWiley · United Kingdom | 1.71Q1 | 5.33 0.13 down from 2023 | 831 | 81% | $5,250 | ||
19Stroke and Vascular NeurologyOABMJ · China | 1.70Q1 | 5.09 0.50 up from 2023 | 234 | 100% | $1,839 | ||
20AddictionWiley · United Kingdom | 1.70Q1 | 4.69 0.25 down from 2023 | 808 | 80% | $4,600 | ||
21International Journal of Drug PolicyElsevier BV · Netherlands | 1.64Q1 | 4.23 0.48 down from 2023 | 815 | 80% | $4,350 | ||
22Substance Abuse Treatment Prevention and PolicyOABioMed Central · United Kingdom | 1.58Q1 | 3.41 0.64 down from 2023 | 240 | 100% | $3,090 | ||
23Journal of NeuroendocrinologyWiley · United Kingdom | 1.58Q1 | 4.77 1.03 up from 2023 | 382 | 74% | $4,550 | ||
24Journal of Intensive CareOABioMed Central · United Kingdom | 1.57Q1 | 5.17 1.51 up from 2023 | 211 | 100% | $2,577 | ||
25Contemporary Drug ProblemsSAGE Publishing · United States | 1.57Q1 | 3.08 0.68 up from 2023 | 79 | 96% | $3,400 | ||
26Addictive Behaviors ReportsOAElsevier BV · United Kingdom | 1.54Q1 | 3.46 0.87 down from 2023 | 170 | 100% | $3,330 | ||
27International Breastfeeding JournalOABioMed Central · United Kingdom | 1.51Q1 | 3.86 0.65 down from 2023 | 253 | 100% | $3,090 | ||
28Influenza and Other Respiratory VirusesOAWiley · United Kingdom | 1.49Q1 | 4.16 0.37 down from 2023 | 364 | 100% | $4,840 | ||
29Current Opinion in Infectious DiseasesLippincott Williams & Wilkins · United States | 1.48Q1 | 4.58 0.16 up from 2023 | 246 | 26% | — | ||
30Clinical EpidemiologyOADove Medical Press · New Zealand | 1.47Q1 | 3.46 0.44 down from 2023 | 345 | 100% | $2,836 | ||
31Infectious Diseases in Obstetrics and GynecologyHindawi Publishing Corporation · United Kingdom | 1.46Q1 | 4.63 1.15 up from 2023 | 39 | 83% | $820 | ||
32Expert Review of VaccinesOAInforma · United States | 1.45Q1 | 4.74 1.49 down from 2023 | 394 | 100% | — | ||
33Annals of HepatologyOAElsevier BV · Mexico | 1.44Q1 | 5.28 1.78 up from 2023 | 303 | 100% | $1,500 | ||
34Journal of NeurotraumaMary Ann Liebert, Inc. · United States | 1.41Q1 | 3.80 0.09 down from 2023 | 592 | 49% | — | ||
35Veterinary ResearchOABioMed Central · United Kingdom | 1.40Q1 | 3.84 0.33 down from 2023 | 381 | 100% | $2,390 | ||
36The Italian Journal of Pediatrics/Italian journal of pediatricsOABioMed Central · United Kingdom | 1.40Q1 | 3.95 0.12 down from 2023 | 595 | 100% | $2,790 | ||
37Psychology of Addictive BehaviorsAmerican Psychological Association · United States | 1.38Q1 | 2.64 0.94 down from 2023 | 298 | 64% | — | ||
38Seminars in Liver DiseaseThieme Medical Publishers (Germany) · United States | 1.38Q1 | 4.08 0.78 down from 2023 | 123 | 38% | — | ||
39VaccineElsevier BV · United Kingdom | 1.38Q1 | 3.84 1.22 down from 2023 | 2,895 | 67% | $3,620 | ||
40DiscoveriesOARomania | 1.36Q1 | 2.25 1.42 down from 2023 | 60 | 100% | — | ||
41Journal of VirologyOAAmerican Society for Microbiology · United States | 1.32Q1 | 3.94 0.20 down from 2023 | 1,761 | 100% | — | ||
42MycosesWiley · Germany | 1.23Q1 | 3.45 1.65 down from 2023 | 392 | 61% | $4,780 | ||
43Substance Abuse Research and TreatmentOASAGE Publishing · United States | 1.23Q1 | 2.91 0.13 up from 2023 | 138 | — | $2,650 | ||
44Journal of Clinical and Translational HepatologyOAUnited States | 1.22Q1 | 4.16 1.09 up from 2023 | 423 | 100% | — | ||
45Journal of Multimorbidity and ComorbidityOASAGE Publishing · United Kingdom | 1.21Q1 | 3.33 0.33 down from 2023 | 82 | 100% | $1,575 | ||
46Journal of NeuroInterventional SurgeryBMJ · United Kingdom | 1.21Q1 | 3.86 0.33 down from 2023 | 902 | 30% | — | ||
47The Clinical NeuropsychologistTaylor & Francis · United Kingdom | 1.18Q1 | 2.87 0.46 down from 2023 | 235 | 41% | — | ||
48Clinical MedicineOARoyal College of Physicians · United Kingdom | 1.17Q2 | 2.60 0.05 down from 2023 | 625 | 100% | $2,500 | ||
49Jornal de PediatriaOAElsevier BV · Brazil | 1.13Q2 | 2.49 0.56 down from 2023 | 290 | 100% | $1,800 | ||
50Journal of Clinical VirologyElsevier BV · Netherlands | 1.13Q2 | 3.54 0.58 down from 2023 | 417 | 75% | $4,210 |
Subfields of Medicine, with Epidemiology highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
75 additional Epidemiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 187
- Window papers (baseline)
- 217,754 +8.7% from indicator year 2021
- Median OJR
- 0.760 +0.6% from indicator year 2021
- Rising journals (2025)
- 17
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 87 | 89 | 94 | 91 | 97 | 108 | 114 | 119 | 129 | 139 | 147 | 157 | 166 | 176 | 187 | 185 | 193 | 198 | 196 | 204 | 196 | 199 | 187 | 178 | |
| Window papers (baseline) | 48,701 | 54,887 | 59,554 | 64,149 | 67,383 | 74,616 | 83,633 | 94,079 | 103,216 | 113,942 | 125,223 | 136,221 | 144,307 | 149,052 | 156,773 | 162,831 | 168,650 | 170,014 | 174,699 | 179,855 | 189,056 | 200,238 | 212,651 | 217,205 | 217,754 | 220,321 | |
| Median OJR | 0.668 | 0.61 | 0.670 | 0.71 | 0.69 | 0.82223 | 0.85 | 0.8287 | 0.835 | 0.86 | 0.8293 | 0.830 | 0.87 | 0.844 | 0.836 | 0.795 | 0.82224 | 0.803 | 0.74 | 0.832 | 0.78 | 0.755 | 0.81 | 0.787 | 0.760 | 0.797 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.